Efficacy and safety of subthreshold micropulse laser in the treatment of central serous chorioretinopathy accompanied by choroidal hemangioma: a case report.

IF 1.7 4区 医学 Q3 OPHTHALMOLOGY
Jiajia Yao, Kai Yang, Juncai He, Li Ran
{"title":"Efficacy and safety of subthreshold micropulse laser in the treatment of central serous chorioretinopathy accompanied by choroidal hemangioma: a case report.","authors":"Jiajia Yao, Kai Yang, Juncai He, Li Ran","doi":"10.1186/s12886-025-03898-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Circumscribed choroidal hemangioma (CCH) is a benign vascular hamartoma caused by congenital vascular malformation. And, central serous chorioretinopathy (CSCR) is a chorioretinal disease characterized by pachychoroid, RPE irregularities, and subretinal fluid (SRF) accumulation. Some literature has indicated a potential correlation between the occurrences of CCH and CSCR.</p><p><strong>Case presentation: </strong>A 59-year-old man presented with blurred vision in his right eye for six months, with an unremarkable history. Multimodal imaging techniques including color fundus photography, fundus autofluorescence (FAF), B-scan ultrasonography (USG), fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and optical coherence tomography (OCT), revealed the presence of CCH accompanying CSCR in the right eye. The patient received treatment with SML for CSCR, while no specific treatment was administered for CCH. The SRF was fully resolved one month after the treatment. At the 3- and 6-month follow-up, SRF resolved, and best-corrected visual acuity (BCVA) improved from 0.6 to 0.9 in the decimal format in the right eye, without notable changes in subfoveal choroidal thickness (SFCT) or the size of CCH.</p><p><strong>Conclusion: </strong>This case reported the coexistence of CCH and CSCR in the right eye, both characterized by choroidal vascular abnormalities. Further research is necessary to determine the favorable effect of SML in patients with CSCR and concurrent CCH.</p>","PeriodicalId":9058,"journal":{"name":"BMC Ophthalmology","volume":"25 1","pages":"75"},"PeriodicalIF":1.7000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11817732/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12886-025-03898-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Circumscribed choroidal hemangioma (CCH) is a benign vascular hamartoma caused by congenital vascular malformation. And, central serous chorioretinopathy (CSCR) is a chorioretinal disease characterized by pachychoroid, RPE irregularities, and subretinal fluid (SRF) accumulation. Some literature has indicated a potential correlation between the occurrences of CCH and CSCR.

Case presentation: A 59-year-old man presented with blurred vision in his right eye for six months, with an unremarkable history. Multimodal imaging techniques including color fundus photography, fundus autofluorescence (FAF), B-scan ultrasonography (USG), fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and optical coherence tomography (OCT), revealed the presence of CCH accompanying CSCR in the right eye. The patient received treatment with SML for CSCR, while no specific treatment was administered for CCH. The SRF was fully resolved one month after the treatment. At the 3- and 6-month follow-up, SRF resolved, and best-corrected visual acuity (BCVA) improved from 0.6 to 0.9 in the decimal format in the right eye, without notable changes in subfoveal choroidal thickness (SFCT) or the size of CCH.

Conclusion: This case reported the coexistence of CCH and CSCR in the right eye, both characterized by choroidal vascular abnormalities. Further research is necessary to determine the favorable effect of SML in patients with CSCR and concurrent CCH.

求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Ophthalmology
BMC Ophthalmology OPHTHALMOLOGY-
CiteScore
3.40
自引率
5.00%
发文量
441
审稿时长
6-12 weeks
期刊介绍: BMC Ophthalmology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of eye disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信